Anti-inflammatory compounds and uses thereof

Details Anti-inflammatory compounds and uses thereof Anti-inflammatory compounds and uses thereof

2011-01-18

2011-01-18

Noakes, Suzanne M (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S324000, C530S329000, C435S002000, C514S789000

Reexamination Certificate

active

07872094

ABSTRACT:
The present invention provides anti-inflammatory compounds, pharmaceutical compositions thereof, and methods of use thereof for treating inflammatory disorders. The present invention also provides methods of identifying anti-inflammatory compounds and methods of inhibiting NF-κB-dependent target gene expression in a cell.

REFERENCES:
patent: 5166133 (1992-11-01), Houston et al.
patent: 5804374 (1998-09-01), Baltimore et al.
patent: 5851812 (1998-12-01), Goeddel et al.
patent: 5939302 (1999-08-01), Goeddel et al.
patent: 5972655 (1999-10-01), Marcu
patent: 6030834 (2000-02-01), Chu et al.
patent: 6831065 (2004-12-01), May et al.
patent: 6864355 (2005-03-01), May et al.
patent: 7049395 (2006-05-01), May et al.
patent: 7534858 (2009-05-01), May et al.
patent: 7538089 (2009-05-01), May et al.
patent: 2002/0156000 (2002-10-01), May et al.
patent: 2003/0054999 (2003-03-01), May et al.
patent: 2005/0143302 (2005-06-01), May et al.
patent: 2006/0293244 (2006-12-01), May et al.
patent: 2009/0286748 (2009-11-01), May et al.
Britta-Mareen, E. et al., “Physphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli,”The EMBO Journal, vol. 14(12):2876-2883 (1995).
Chu, Z-L. et aL, “IKKΥ Mediates the Interaction of Cellular IκB Kinase with the Tax Transforming Protein of Human T Cell Leukemia Virus Type 1.”The Journal of Biological Chemistry, vol. 274, No. 22, pp. 15297-15300 (1999).
Delhase, et al., “Positive and Negative Regulation of IκB Kinase Activity Through IKK beta Subunit Phosphorylation.”Science, vol. 284, pp. 309-313 (1999).
DiDonato, J.A. et al., “A cytokine-responsive IκB Kinase that activates the transcription factor NF—κB.”Nature, vol. 388, pp. 548-554 (1997).
DiDonato, J.A. et al., “Mapping of the Inducible IκB Phosphorylation Sites That Signal Its Ubiquitination and Degradation.”Molecular and Cellular Biology, vol. 16, No. 4, pp. 1295-1304 (1996).
Ghosh, S. et aL, “NF-κB and Rel Proteins: Evolutionarily Conserved Mediators of Immune Responses.”Annu. Rev. Immunol. vol. 16, pp. 225-260 (1998).
Huang, Cheng-Han et al., “Remodeling of the Transmembrane Segment in Human Glycophorin by Aberrant RNA Splicing,”The Journal of Biological Chemistry, vol. 269(14):10804-10812 (1994).
Harhaj, E.W. et al., “IKKγ Serves as a Docking Subunit of the IκB Kinase (IKK) and Mediates Interaction of IKK with the Human T-cell Leukemia Virus Tax Protein.”The Journal of Biological Chemistry, vol. 274, No. 33, pp. 22911-22914 (1999).
Hatada, Eunice N., et al. NF-kappaB and the Innate Immune Response.Current Opinion in Immunology, vol. 12, pp. 52-58 (2000).
Houston et al., “Method for inhibiting adhesion of white blood cells to endothelial cells,” Database: Issued—Patents—AA, Accession No.: US-07-700-526-17, Aug. 16, 1991.
Hu, Y. et al., “Abnormal Morphogenesis but Intact IKK Activation in Mice lacking the IKKα Subunit of IκB Kinase.”Science, vol. 284, pp. 316-320 (1999).
Israël, A., “The IKK complex: An Integrator of All Signals that Activate NF-kappaB?”Trends in Cell Biology, vol. 10, pp. 129-133 (2000).
Jin, Dong-Yan et al., “Role of Adapter Function in Oncoprotein-mediated Activation of NF-κB,”The Journal of Biological Chemistry, vol. 274(25):17402-17405 (1999).
Jin, Dong-Yan et al., “Isolation of Full-Length cDNA and Chromosomal Localization of Human NF-κB Modulator NEMO to Xq28,”Journal of Biomedical Science, vol. 6:115-120 (1999).
Karin, M., et al., “Phosphorylation Meets Ubiquitination: The Control of NF-kappaB Activity”,Annual Review of Immunology, vol. 18, pp. 621-663 (2000).
Kopp, E. et al., “Inhibiton of NF-κB by Sodium Salicylate and Aspirin.”Science, vol. 265, pp. 956-959 (1994).
Li, Q. et al., “Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene.”Science, vol. 284, pp. 321-325 (1999).
May, M.J. et al. “Rel/NF-κB and IκB proteins: an overview.”Cancer Biology, vol. 8 pp. 63-73 (1997).
May, M.J. et al. “Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex.”Science. vol. 289, No. 5484, pp. 1550-4 (2000).
May, M.J. et al. “Signal Transduction through NF-κB.”Immunolgy Today, vol. 19, No. 2, pp. 80-88 (1998).
Mercurio, F. et al., “IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex.” Molecular and Cellular Biology, vol. 19, No. 2, pp. 1526-1538 (1999).
Mock, et al., “A Conserved Helix-Loop-Helix Ubiquitous Kinase, Maps to Human Chromosome 10 and Mouse Chromosome 19.”Genomicsvol. 27, pp. 348-351 (1995).
Ngo, et al., in “The Protein Folding Problem and Tertiary Structure Prediction”, Merz, et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495 (1994).
Regnier, C.H. et al., “Identification and Characterization of an IκB Kinase.”Cell, vol. 90, pp. 373-383 (1997).
Rothwarf, D.M. et al., “IKK-γ is an essential regulatory subunit of the IκB kinase complex.”Nature, vol. 395, pp. 297-300 (1998).
Rudolph, D. et al., “Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice.”Genes&Development, vol. 14, pp. 854-862 (2000).
Siebenlist, U. et al., “Structure, Regulation and Function of NF- κB.”Annu. Rev. Cell. Biol., vol. 10, pp. 405-455 (1994).
Takeda, K. et al., “Limb and Skin Abnormalities in Mice Lacking IKKα.”Science, vol. 284, pp. 313-316 (1999).
Yamaoka, S. et al., “Complementation Cloning of NEMO, a Component of the IκB Activation.”Cell, vol. 93, pp. 1231-1240 (1998).
Ye, J. et al., “Regulation of the NF-κB Activation Pathway by Isolated Domains of FIP3/IKKγ, a Component of the IκB-γ Kinase Complex.”The Journal of Biological Chemistry, vol. 275, No. 13, pp. 9882-9889 (2000).
Zandi, E. et al. “The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation.”Cell. vol. 91, No. 2, pp. 243-252 (1997).
Zhang, S. Q. et al., “Recruitment of the IKK Signalosome to the p55 TNF Receptor: RIP and A20 Bind to NEMO (IKK γ) upon Receptor Stimulation.”Immmunity, vol. 12, pp. 301-311 (2000).
Zhong, H. et al., “The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP-Independent Mechanism.”Cell, vol. 89, pp. 413-424 (1997).

Affiliated with

Also associated with

Rating

Anti-inflammatory compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-inflammatory compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory compounds and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2631985